EARNEST Partners’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-49
Closed -$549 380
2023
Q3
$549 Hold
49
﹤0.01% 1112
2023
Q2
$392 Hold
49
﹤0.01% 1129
2023
Q1
$397 Hold
49
﹤0.01% 1126
2022
Q4
$417 Hold
49
﹤0.01% 1131
2022
Q3
$0 Hold
49
﹤0.01% 1127
2022
Q2
$0 Hold
49
﹤0.01% 1149
2022
Q1
$1K Hold
49
﹤0.01% 1070
2021
Q4
$1K Hold
49
﹤0.01% 1084
2021
Q3
$1K Hold
49
﹤0.01% 1091
2021
Q2
$1K Hold
49
﹤0.01% 1093
2021
Q1
$2K Hold
49
﹤0.01% 1005
2020
Q4
$1K Hold
49
﹤0.01% 1083
2020
Q3
$1K Hold
49
﹤0.01% 1034
2020
Q2
$1K Hold
49
﹤0.01% 1016
2020
Q1
$1K Hold
49
﹤0.01% 965
2019
Q4
$1K Hold
49
﹤0.01% 1076
2019
Q3
$1K Hold
49
﹤0.01% 1058
2019
Q2
$1K Hold
49
﹤0.01% 1076
2019
Q1
$1K Hold
49
﹤0.01% 1082
2018
Q4
$1K Hold
49
﹤0.01% 1058
2018
Q3
$1K Hold
49
﹤0.01% 1096
2018
Q2
$1K Hold
49
﹤0.01% 1103
2018
Q1
$1K Hold
49
﹤0.01% 1079
2017
Q4
$1K Buy
+49
New +$777 ﹤0.01% 1074

Other funds holding BHC

EARNEST Partners's BHC Position: Q4 2023 in Review

EARNEST Partners sold out of Bausch Health (BHC) in Q4 2023, closing a stake of 49 shares — an estimated $549 sold.

EARNEST Partners first reported a position in BHC in Q4 2017 and held it in 24 quarters. The position peaked at $2K in Q1 2021. 234 funds tracked by Wall St. Rank hold BHC as of Q4 2023.

  • EARNEST Partners reported no remaining Bausch Health position as of Q4 2023 after selling out during the quarter.
  • EARNEST Partners sold 49 Bausch Health shares in Q4 2023, an estimated $549.
  • EARNEST Partners first reported a position in Bausch Health in Q4 2017 and held it in 24 quarters.
  • EARNEST Partners's Bausch Health position peaked at $2K in Q1 2021.
  • 234 funds tracked by Wall St. Rank held Bausch Health as of Q4 2023.

Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.